MDC 2 EXAM 1 2026 PRACTICE QUESTION SET
ONE
◉ Diagnosis(Surgical classification type). Answer: removal for
testing or examination to rule out cancer "biopsy"
◉ Cure(Surgical classification type). Answer: removes all cancerous
tissue
◉ Control(Surgical classification type). Answer: removes part of
tumor when removal of entire tumor is impossible
◉ Palliation. Answer: surgery to provide symptom relief, is NOT
curative
◉ Assessing therapy effectiveness. Answer: (Surgical classification
type)
◉ Reconstruction(Surgical classification type). Answer: increases
function or appearance or both.
,◉ S/E of Surgery. Answer: removal can lead to changes in
appearance, activity level, depression, grief, and decreased
enjoyment of life
◉ S/E of Radiation. Answer: Acute and long-term site-specific
changes, vary according to site, Local skin changes and hair loss,
altered taste sensations, Fatigue, Bone marrow suppression.
◉ S/E of Chemotherapy. Answer: extravasation,
infection risk,
bone marrow suppression,
neutropenia,
anemia,
thrombocytopenia,
clotting risks,
chemotherapy-induced nausea and vomiting, mucositis,
alopecia,
cognitive changes,
chemotherapy-induced peripheral neuropathy.
◉ S/E of Immunotherapy Monocle antibodies. Answer: allergic
reactions,
skin,
,mucous membranes,
GI tract
◉ S/E of Immunotherapy Tyrosine kinase inhibitors. Answer: Fluid
retention,
electrolyte imbalances,
bone marrow suppression
◉ S/E of Immunotherapy EGFRI's. Answer: skin reactions,
adverse effects on heart
◉ S/E of Immunotherapy VEGF's. Answer: hypertension,
impaired wound healing,
bone marrow suppression
◉ S/E of Immunotherapy Multikinase inhibitors. Answer:
hypertension,
GI distress,
mucositis,
mild neutropenia
thrombocytopenia
, ◉ S/E of Immunotherapy Proteasome inhibitors. Answer: GI
distress,
decreased taste sensation,
peripheral neuropathy
◉ S/E of Immunotherapy Angiogenesis inhibitors. Answer: bone
marrow suppression,
headache,
GI distress,
muscle pain
joint pain
◉ S/E of Photodynamic therapy. Answer: avoid sunlight?
◉ S/E of Hormonal manipulation. Answer: Masculinizing effects in
women.
Feminizing effects in men (gynecomastia).
Fluid retention.
Acne.
Hypercalcemia.
Liver dysfunction.
Venous thromboembolism
ONE
◉ Diagnosis(Surgical classification type). Answer: removal for
testing or examination to rule out cancer "biopsy"
◉ Cure(Surgical classification type). Answer: removes all cancerous
tissue
◉ Control(Surgical classification type). Answer: removes part of
tumor when removal of entire tumor is impossible
◉ Palliation. Answer: surgery to provide symptom relief, is NOT
curative
◉ Assessing therapy effectiveness. Answer: (Surgical classification
type)
◉ Reconstruction(Surgical classification type). Answer: increases
function or appearance or both.
,◉ S/E of Surgery. Answer: removal can lead to changes in
appearance, activity level, depression, grief, and decreased
enjoyment of life
◉ S/E of Radiation. Answer: Acute and long-term site-specific
changes, vary according to site, Local skin changes and hair loss,
altered taste sensations, Fatigue, Bone marrow suppression.
◉ S/E of Chemotherapy. Answer: extravasation,
infection risk,
bone marrow suppression,
neutropenia,
anemia,
thrombocytopenia,
clotting risks,
chemotherapy-induced nausea and vomiting, mucositis,
alopecia,
cognitive changes,
chemotherapy-induced peripheral neuropathy.
◉ S/E of Immunotherapy Monocle antibodies. Answer: allergic
reactions,
skin,
,mucous membranes,
GI tract
◉ S/E of Immunotherapy Tyrosine kinase inhibitors. Answer: Fluid
retention,
electrolyte imbalances,
bone marrow suppression
◉ S/E of Immunotherapy EGFRI's. Answer: skin reactions,
adverse effects on heart
◉ S/E of Immunotherapy VEGF's. Answer: hypertension,
impaired wound healing,
bone marrow suppression
◉ S/E of Immunotherapy Multikinase inhibitors. Answer:
hypertension,
GI distress,
mucositis,
mild neutropenia
thrombocytopenia
, ◉ S/E of Immunotherapy Proteasome inhibitors. Answer: GI
distress,
decreased taste sensation,
peripheral neuropathy
◉ S/E of Immunotherapy Angiogenesis inhibitors. Answer: bone
marrow suppression,
headache,
GI distress,
muscle pain
joint pain
◉ S/E of Photodynamic therapy. Answer: avoid sunlight?
◉ S/E of Hormonal manipulation. Answer: Masculinizing effects in
women.
Feminizing effects in men (gynecomastia).
Fluid retention.
Acne.
Hypercalcemia.
Liver dysfunction.
Venous thromboembolism
